Hospice Clinical Manager Subscription

Protein degradation therapies are gaining recognition for their ability to address previously untreatable conditions. PROTAC molecules function by recruiting cellular machinery to break down specific proteins linked to disease progression.

This innovative mechanism opens new possibilities in oncology and rare disease research. Pharmaceutical scientists are actively developing optimized PROTAC compounds with improved stability and selectivity.

As clinical research advances, protein-targeting strategies could transform the future of precision medicine.